QLC-1101
- Generic Name
- QLC-1101
The Food Effect on Pharmacokinetics Study of QLC1101 in Healthy Subjects
- First Posted Date
- 2025-05-20
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT06980909
A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Colorectal CancerPancreatic CancerNon-small Cell Lung CancerSolid Tumor
- Interventions
- First Posted Date
- 2024-05-08
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Target Recruit Count
- 250
- Registration Number
- NCT06403735
- Locations
- 🇨🇳
The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong, China
🇨🇳Harbin Medical university cancer hospital, Ha'erbin, Heilongjiang, China
🇨🇳Jiangxi Cancer Hospital, Nanchang, Jiangxi, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath